AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Apoptosis assays could be used to detect selective toxicity of anticancer drugs.

Women's Health Weekly

| November 06, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 NOV 6 - (NewsRx.com & NewsRx.net) -- Apoptosis assays could be used to detect selective toxicity of anticancer drugs.

"The goal of our study was to determine whether an apoptosis assay used after short-term drug exposure could predict selective toxicity to cancer cells. To this end we compared the effect of 8 anticancer drugs and 10 toxic compounds without known antitumor activity in cultures of human breast cancer cells and normal diploid fibroblasts by Apoptosis ELISA and growth inhibition assays," investigators in the United States report.

"There was an overlap in concentration values of drugs and toxins inhibiting proliferation in cancer cells. In contrast, Apoptosis ELISA clearly distinguished between the two groups of compounds," wrote O.S. Frankfurt and colleagues, University of Miami School of Medicine.

"Anticancer drugs induced apoptosis in cancer cells at 0.0015-0.5 microM, while toxins were effective at much higher concentrations of 8.050 microM. Moreover, six out of the 10 toxins did not induce apoptosis in cancer cells," the researchers wrote.

"The normal:cancer cell (N:C) ratio for growth-inhibiting concentrations was in a similar range for anticancer drugs and ...

Related articles from newspapers, magazines, journals, and more
In the UK, Cancer Research Technology (CRT), The Institute of Cancer Research...
Magazine article from: Chemistry and Industry July 13, 2009 700+ words
...collaboration to develop potential anticancer drugs that target molecular 'chaperones', which support the growth of cancer cells. Molecular chaperones play...Research has suggested that in cancer cells the same chaperones contribute...
Apoptosis assays could be used to detect selective toxicity of anticancer drugs.
Newspaper article from: Drug Week November 7, 2003 700+ words
...Medicine. "Anticancer drugs induced apoptosis in cancer cells at 0.0015...toxicity of anticancer drugs by determining...induction in cancer cells or through...toxicity to cancer cells. Anticancer Drugs, 2003;14...
Geron and Pharmacia & Upjohn announce signing of agreement to develop new class...
Press release article from: Business Wire March 24, 1997 700+ words
...collaborate in the discovery, development and commercialization of a new class of anticancer drugs that inhibit telomerase, an enzyme responsible for making cancer cells immortal. The agreement will become effective upon receipt of regulatory approval...
Precious anticancer drugs: platinum's leading role in anticancer therapy may...
Magazine article from: Chemistry and Industry Sadler, Peter March 9, 2009 700+ words
...of cytotoxic anticancer drugs and has no particular...normal as well as cancer cells. The key was...nuclei of bladder cancer cells. Photoactivation...reactive species in cancer cells. But what are...designing novel anticancer drugs based on other...
Anticompression therapies could open up tumors to anticancer drugs.
Newspaper article from: Health & Medicine Week March 8, 2004 700+ words
...Rapidly proliferating cancer cells can squash the blood...making it difficult for anticancer drugs to reach and destroy...Hospital, grafted human cancer cells into mice. When the...route for spreading cancer cells (Padera TP, Stoll...
ROYAL SOCIETY OF CHEMISTRY: New anticancer drugs for the new millennium.
Press release article from: M2 Presswire February 25, 1999 700+ words
...cellular processes in cancer cells. Such drugs should...toxic than current anticancer drugs, as well as faster...precise signals that cancer cells need to divide, to...systems for testing anticancer drugs. Other speakers at...
Anticancer drugs: in vivo la difference! (drug resistance)
Magazine article from: Science News Decker, C. March 24, 1990 700+ words
...develop resistance to anticancer drugs, chemotherapy becomes...displayed by breast-cancer cells in mice vanished when...and processing of anticancer drugs differed between mice...injecting breast-cancer cells into four groups of...
Lorus Therapeutics allowed Canadian patent to protect its novel anticancer...
Press release article from: PR Newswire November 10, 2004 700+ words
...Therapeutics is focused on developing anticancer drugs which complement the efficacy...frequently over-expressed in cancer cells, and has been shown to cooperate...building a portfolio of promising anticancer drugs. Late-stage clinical development...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA